Prexa Pharmaceuticals Inc — Form D

Prexa Pharmaceuticals Inc of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-04-29. The offering totals $7.0M, of which $3.3M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2011-04-29
• Form: D
• Accession: 0001381209-11-000005
• Industry: Pharmaceuticals
• Exemptions: 06
• Total offering: $7.0M
• Amount sold: $3.3M
• Remaining: $3.8M
• Investors: 4
• Date of first sale: 2011-04-15
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-159077

Issuer

• Name: Prexa Pharmaceuticals Inc
• CIK: 0001381209
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2006
• Address: 184 HIGH STREET, 4TH FLOOR, Boston, MA, 02110
• Phone: 857-366-8462

Officers, directors & promoters (9)

More

• CIK 1381209 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search